Cost-Effectiveness of Introducing a Rotavirus Vaccine in Developing Countries: The Case of Mexico

This study, published in BMC Infectious Diseases, developed a model to compare the cost and disease burden of rotavirus in unvaccinated children in Mexico. The study determined that it would be highly cost-effective to include rotavirus vaccine in the national immunization program, especially among poorer populations and those with less access to medical care.

Author(s): Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R

Published: 2008

  • Visit web page (English)

    (Located at www.pubmedcentral.nih.gov)

    Citation: Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R. Cost-effectiveness of Introducing a Rotavirus Vaccine in Developing Countries: The Case of Mexico. BMC Infectious Diseases. 2008;8:103-116.